Clever Leaves (NASDAQ:CLVR – Get Free Report) is anticipated to release its results on Friday, November 13th. Analysts expect the company to post earnings of ($10.95) per share and revenue of $4.05 million for the quarter.
Clever Leaves Price Performance
Clever Leaves stock opened at $0.00 on Wednesday. Clever Leaves has a 1-year low of $0.00 and a 1-year high of $0.50. The company has a market capitalization of $1,755.00, a P/E ratio of -0.00 and a beta of 4,092.58.
About Clever Leaves
Clever Leaves Holdings Inc. was a Colombian pharmaceutical cannabis company focused on cultivating, processing and distributing cannabinoid-based products. Its operations were centered on the production of pharmaceutical-grade cannabis extracts, active pharmaceutical ingredients and other bulk cannabinoid products for medical and research applications. Founded in 2016, the company developed cultivation and processing operations in Colombia and Portugal, with the goal of supplying regulated medical cannabis and pharmaceutical markets internationally.
Read More
- Five stocks we like better than Clever Leaves
- Why Kinder Morgan’s Chairman Just Bought $15 Million in Stock
- Rocket Lab’s Record Backlog Could Fuel a Rebound, But Neutron Raises the Stakes
- Don’t Let Their Low Yields Fool You: 3 Dividend Stocks Worth Watching
- A $4 Billion Jolt: NRG Energy Powers Data Center Ambitions
Receive News & Ratings for Clever Leaves Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clever Leaves and related companies with MarketBeat.com's FREE daily email newsletter.
